Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC104389.2 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-15 |
mRNA | SLC4A1 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-15 |
mRNA | PKLR | GDSC1000 | pan-cancer | AAC | 0.28 | 3e-15 |
mRNA | IKZF4 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-15 |
mRNA | STAT5A | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-15 |
mRNA | LYL1 | GDSC1000 | pan-cancer | AAC | 0.41 | 6e-15 |
mRNA | GYPE | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-14 |
mRNA | C10orf128 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-14 |
mRNA | UBAC1 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-14 |
mRNA | CD69 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-14 |